Bristol-Myers Squibb’s (NYSE:BMY) $7 billion acquisition of Amylin Phramaceuticals (NASDAQGS:AMLN) is one of the largest diabetes deals for the year to date. Given Bristol-Myers Squibb’s and AstraZeneca’s (NYSE:AZN) five-year-old diabetes drug development alliance, the latest deal stands to position them in stronger competition with Sanofi, Novo Nordisk and Merck. As part of the deal, AstraZeneca […]
A U.S. Food and Drug committee moved against recommending for approval Sanofi-Aventis’ (NYSE:SNY) blood thinner for patients on chemotherapy in a resounding 14 to 1 vote against semuloparin. Semuloparin was designed to treat patients with certain cancers at higher risk for blood clots. The oncologic drugs advisory committee said the findings of the phase 3 […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Evozym Biologics, founded in 2009 by Antarctic research scientists at the University of Delaware and the Desert Research Institute, has raised $600,000 to fund business development and strategic partnerships for its gene discovery software and database business. Funding for the Lewes, Delaware company came from core investors, said Joseph Grzymski, the president and co-founder of […]